Receptor group

Muscarinic acetylcholine receptors

5 related receptors and the ligands measured at several of them.

Binding affinity (Kᵢ)

9 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
LigandM1 receptorM2 receptorM3 muscarinic receptorM4 receptorM5 receptor
Atropine
Hyoscyamine
DOI
Arecoline
Scopolaminenot measured
MDMA
2C-E
2C-B
DOB
Atropine at M1: Kᵢ 0.46 nM, Huang et al. 2001Atropine at M2: Kᵢ 1.1 nM, Huang et al. 2001Atropine at M3 muscarinic: Kᵢ 0.71 nM, other reports differ, Huang et al. 2001Atropine at M4: Kᵢ 1.1 nM, other reports differ, Huang et al. 2001Atropine at M5: Kᵢ 0.24 nM, other reports differ, Moriya et al. 1999Hyoscyamine at M1: Kᵢ 0.33 nM, Ghelardini et al. 1997Hyoscyamine at M2: Kᵢ 0.35 nM, Ghelardini et al. 1997Hyoscyamine at M3 muscarinic: Kᵢ 0.50 nM, Ghelardini et al. 1997Hyoscyamine at M4: Kᵢ 0.28 nM, Ghelardini et al. 1997Hyoscyamine at M5: Kᵢ 0.58 nM, Ghelardini et al. 1997DOI at M1: Kᵢ 2720 nM, Ray 2010DOI at M2: Kᵢ 1989 nM, Ray 2010DOI at M3 muscarinic: Kᵢ 1428 nM, Ray 2010DOI at M4: Kᵢ 578 nM, Ray 2010DOI at M5: Kᵢ 2208 nM, Ray 2010Arecoline at M1: Kᵢ 1862 nM, Jakubík et al. 1997Arecoline at M2: Kᵢ 5754 nM, Jakubík et al. 1997Arecoline at M3 muscarinic: Kᵢ 3802 nM, Jakubík et al. 1997Arecoline at M4: Kᵢ 3548 nM, Jakubík et al. 1997Arecoline at M5: Kᵢ 7000 nM, Ozenil et al. 2020Scopolamine at M1: Kᵢ 1.1 nM, Huang et al. 2001Scopolamine at M2: Kᵢ 2.1 nM, Huang et al. 2001Scopolamine at M3 muscarinic: Kᵢ 0.39 nM, Huang et al. 2001Scopolamine at M4: Kᵢ 0.34 nM, Huang et al. 2001MDMA at M3 muscarinic: Kᵢ 1851 nM, Ray 2010MDMA at M4: Kᵢ 8245 nM, Ray 2010MDMA at M5: Kᵢ 6330 nM, Ray 2010MDMA at M1: Kᵢ of 10 µM or weakerMDMA at M2: Kᵢ of 10 µM or weaker2C-E at M3 muscarinic: Kᵢ 2556 nM, Ray 20102C-E at M5: Kᵢ 1725 nM, Ray 20102C-E at M1: Kᵢ of 10 µM or weaker2C-E at M2: Kᵢ of 10 µM or weaker2C-E at M4: Kᵢ of 10 µM or weaker2C-B at M3 muscarinic: Kᵢ 822 nM, Ray 20102C-B at M1: Kᵢ of 10 µM or weaker2C-B at M2: Kᵢ of 10 µM or weaker2C-B at M4: Kᵢ of 10 µM or weaker2C-B at M5: Kᵢ of 10 µM or weakerDOB at M3 muscarinic: Kᵢ 1152 nM, Ray 2010DOB at M1: Kᵢ of 10 µM or weakerDOB at M2: Kᵢ of 10 µM or weakerDOB at M4: Kᵢ of 10 µM or weakerDOB at M5: Kᵢ of 10 µM or weakerM1 receptorM1M2 receptorM2M3 muscarinic receptorM3 muscarinicM4 receptorM4M5 receptorM5Atropine, Kᵢ: M1 0.46 nM, M2 1.1 nM, M3 muscarinic 0.71 nM, M4 1.1 nM, M5 0.24 nMAtropineHyoscyamine, Kᵢ: M1 0.33 nM, M2 0.35 nM, M3 muscarinic 0.50 nM, M4 0.28 nM, M5 0.58 nMHyoscyamineDOI, Kᵢ: M1 2720 nM, M2 1989 nM, M3 muscarinic 1428 nM, M4 578 nM, M5 2208 nMDOIArecoline, Kᵢ: M1 1862 nM, M2 5754 nM, M3 muscarinic 3802 nM, M4 3548 nM, M5 7000 nMArecolineScopolamine, Kᵢ: M1 1.1 nM, M2 2.1 nM, M3 muscarinic 0.39 nM, M4 0.34 nMScopolamineMDMA, Kᵢ: M1 10 µM or weaker, M2 10 µM or weaker, M3 muscarinic 1851 nM, M4 8245 nM, M5 6330 nMMDMA2C-E, Kᵢ: M1 10 µM or weaker, M2 10 µM or weaker, M3 muscarinic 2556 nM, M4 10 µM or weaker, M5 1725 nM2C-E2C-B, Kᵢ: M1 10 µM or weaker, M2 10 µM or weaker, M3 muscarinic 822 nM, M4 10 µM or weaker, M5 10 µM or weaker2C-BDOB, Kᵢ: M1 10 µM or weaker, M2 10 µM or weaker, M3 muscarinic 1152 nM, M4 10 µM or weaker, M5 10 µM or weakerDOB
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human Kᵢ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

stronger weaker≥ 10 µM measured, 10 µM or weakerempty not measured* other reports differ† source not traced to the original

Human values only. A cell shows the value displayed on the compound page, from one assay. Values from different assays are not directly interchangeable, and a value does not establish clinical potency or safety.